Research Article
[Retracted] Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
Table 1
Association of FTO with clinical data of NSCLC patients (n, %).
| | Index | Relative expression of FTO | value | | High expression (n = 30) | Low expression (n = 30) |
| | Age | | ≥60 years (n = 33) | 13 | 20 | 0.069 | | <60 years (n = 27) | 17 | 10 | | Gender | | Male (n = 35) | 20 | 15 | 0.190 | | Female (n = 25) | 10 | 15 | | Tumour size | | ≥3 cm (n = 30) | 17 | 13 | 0.302 | | <3 cm (n = 30) | 13 | 17 | | Clinical stage | | I + II (n = 37) | 13 | 24 | | | III + IV (n = 23) | 17 | 6 | | Lymph node metastasis | | Yes (n = 18) | 14 | 4 | | | None (n = 42) | 16 | 26 | | Tumour type | | Squamous cell carcinoma (n = 27) | 15 | 12 | 0.436 | | Adenocarcinoma (n = 33) | 15 | 18 |
|
|
Note. denotes a notable difference. |